Detalles de la búsqueda
1.
Increased mRNA expression of ADAMs in renal cell carcinoma and their association with clinical outcome.
Oncol Rep
; 11(2): 529-36, 2004 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-14719095
2.
The tumour-targeting human L19-IL2 immunocytokine: preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma.
Eur J Cancer
; 46(16): 2926-35, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20797845
3.
The ratio of prostate-specific antigen (PSA) to prostate volume (PSA density) as a parameter to improve the detection of prostate carcinoma in PSA values in the range of < 4 ng/mL.
Cancer
; 104(5): 993-1003, 2005 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16007682
4.
The membrane proteases adams and hepsin are differentially expressed in renal cell carcinoma. Are they potential tumor markers?
J Urol
; 172(6 Pt 1): 2162-6, 2004 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-15538223
Resultados
1 -
4
de 4
1
Próxima >
>>